Merck & Co. Inc. buy Royal Bank of Canada
Start price
25.02.26
/
50%
€105.40
Target price
25.02.27
€120.47
Performance (%)
-2.09%
Price
30.03.26
€103.20
Summary
This prediction is currently active. With a performance of -2.09%, the BUY prediction for Merck & Co. Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 25.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 3.614% | 3.614% |
| iShares Core DAX® | -1.665% | -10.870% |
| iShares Nasdaq 100 | -3.766% | -5.147% |
| iShares Nikkei 225® | -2.803% | -11.299% |
| iShares S&P 500 | -2.299% | -4.801% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€102.80
30.03.26
30.03.26
€123.30
30.03.27
30.03.27
0.39%
30.03.26
30.03.26
